DataMEDS AI Amends LOI to License and Acquire Healthcare Technology IP
DataMEDS AI entered into an amended and restated letter of intent to license and acquire intellectual property enabling prescription-drug telehealth, medical drones and healthcare blockchain technologies.
Story updates
11:44:18 AM UTC
SquawkNews
DataMEDS AI, Inc. entered an amended, non-binding LOI to license and acquire IP from multiple parties for telehealth, drone delivery and data platforms, aiming to close in Q4 2026, subject to definitive agreements, due diligence and Nasdaq requirements.Material DetailsContext by AI AnalystThis is a…
TAMPA, FL / / October 22, 2026 / DataMEDS AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") NASDAQ:MEDS, a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx™ artificial intelligence platform and PharmacyChain™ bl…